Paolo Cavazza, 10% Owner at SCICLONE PHARMACEUTICALS INC (SCLN), bought 54,119 shares at $2.05 ($111K) on 2007-11-02, disclosed to the SEC on 2007-11-05.
Open-market purchase of $111k SCLN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 25,000 | $51K | 46.2% |
| 2 | $2.05 | 29,119 | $60K | 53.8% |
| Total | $2.05 avg | 54,119 | $111K | 100% |
| Filing → |
| SNGX | SELL | 2017-12-01 | $1.2M | — | Filing → |
| SCLN | SELL | 2012-05-02 | $33.2M | — | Filing → |
| RGRX.OB | BUY | 2011-01-07 | $600K | — | Filing → |